Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
- PMID: 9603117
- DOI: 10.1164/ajrccm.157.5.9709032
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
Abstract
Exacerbations occur commonly in patients with moderate or severe chronic obstructive pulmonary disease (COPD) but factors affecting their severity and frequency or effects on quality of life are unknown. We measured daily peak expiratory flow rate (PEFR) and daily respiratory symptoms for 1 yr in 70 COPD patients (52 male, 18 female, mean age [+/- SD] 67.5 +/- 8.3 yr, FEV1 1.06 +/- 0.45 L, FVC 2.48 +/- 0.82 L, FEV1/FVC 44 +/- 15%, FEV1 reversibility 6.7 +/- 9.1%, PaO2 8.8 +/- 1.1 kPa). Quality of life was measured by the St. George's Respiratory Questionnaire (SGRQ). Exacerbations (E) were assessed at acute visit (reported exacerbation) or from diary card data each month (unreported exacerbation). In 61 (87%) patients there were 190 exacerbations (median 3; range, 1 to 8) of which 93 (51%) were reported. There were no differences in major symptoms (increase in dyspnea, sputum volume, or purulence) or physiological parameters between reported and unreported exacerbations. At exacerbation, median peak flow fell by an average of 6.6 L/min (p = 0.0003). Using the median number of exacerbations as the cutoff point, patients were classified as infrequent exacerbators (E = 0 to 2) or frequent exacerbators (E = 3 to 8). The SGRQ Total and component scores were significantly worse in the group that had frequent exacerbations: SGRQ Total score (mean difference = 14.8, p < 0.001), Symptoms (23.1, p < 0.001), Activities (12.2, p = 0.003), Impacts (13.9, p = 0.002). However there was no difference between frequent and infrequent exacerbators in the fall in peak flow at exacerbation. Factors predictive of frequent exacerbations were daily cough (p = 0.018), daily wheeze (p = 0.011), and daily cough and sputum (p = 0.009) and frequent exacerbations in the previous year (p = 0.001). These findings suggest that patient quality of life is related to COPD exacerbation frequency.
Similar articles
-
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2000 May;161(5):1608-13. doi: 10.1164/ajrccm.161.5.9908022. Am J Respir Crit Care Med. 2000. PMID: 10806163
-
Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.Thromb Haemost. 2000 Aug;84(2):210-5. Thromb Haemost. 2000. PMID: 10959691
-
Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?Int J Chron Obstruct Pulmon Dis. 2015 Mar 10;10:525-33. doi: 10.2147/COPD.S76475. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25792820 Free PMC article.
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
-
Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: A meta-analysis.Int J Surg. 2020 Jun;78:28-35. doi: 10.1016/j.ijsu.2020.04.010. Epub 2020 Apr 15. Int J Surg. 2020. PMID: 32304896 Review.
Cited by
-
The impact of body mass index on inpatient- versus outpatient-treated chronic obstructive pulmonary disease exacerbations.Can Respir J. 2013 Jul-Aug;20(4):237-42. doi: 10.1155/2013/131072. Epub 2013 May 28. Can Respir J. 2013. PMID: 23717822 Free PMC article.
-
Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD.BMJ Open Respir Res. 2015 Jan 15;2(1):e000069. doi: 10.1136/bmjresp-2014-000069. eCollection 2015. BMJ Open Respir Res. 2015. PMID: 25628892 Free PMC article.
-
The Role of Human Leukocyte Antigen-DR in Regulatory T Cells in Patients with Virus-Induced Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Med Sci Monit. 2021 Mar 2;27:e928051. doi: 10.12659/MSM.928051. Med Sci Monit. 2021. PMID: 33651771 Free PMC article.
-
Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study.Int J Chron Obstruct Pulmon Dis. 2015 Feb 17;10:379-88. doi: 10.2147/COPD.S71413. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25733827 Free PMC article.
-
Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients.Sci Rep. 2016 Jun 28;6:28698. doi: 10.1038/srep28698. Sci Rep. 2016. PMID: 27350308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources